Fig. 5From: Toll-like receptors and toll-like receptor-targeted immunotherapy against gliomaTLR agonists and combinatorial treatment. The green box represents TLR agonists, the gray box represents dual treatment with TLR agonists, the blue texts indicate in vivo or in vitro experiments, and the black texts indicate clinical trialsBack to article page